Clinical Trials Browser

Phase 2 × Advanced Colorectal Cancer × durvalumab × Clear all

NCT02227667 2021-06-18

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Phase 2 Completed

16 enrolled 9 charts

Gastrointestinal

Advanced Colorectal Cancer